Immuno-genomic profiling of biopsy specimens predicts neoadjuvant chemotherapy response in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive cancers and is primarily treated with platinum-based neoadjuvant chemotherapy (NAC). Some ESCCs respond well to NAC. However, biomarkers to predict NAC sensitivity and their response mechanism in ESCC remain unclear. We perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasagawa, Shota, Kato, Hiroaki, Nagaoka, Koji, Sun, Changbo, Imano, Motohiro, Sato, Takao, Johnson, Todd A., Fujita, Masashi, Maejima, Kazuhiro, Okawa, Yuki, Kakimi, Kazuhiro, Yasuda, Takushi, Nakagawa, Hidewaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418738/
https://www.ncbi.nlm.nih.gov/pubmed/35944530
http://dx.doi.org/10.1016/j.xcrm.2022.100705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418738/
https://www.ncbi.nlm.nih.gov/pubmed/35944530
http://dx.doi.org/10.1016/j.xcrm.2022.100705

Ejemplares similares